FASLG and COVID-19: Furthermore, a previous study also showed a high prevalence of antiphospholipid antibodies (aPL) in patients with COVID19, with a recent meta-analysis and systematic review reporting that the most frequent type of aPL was lupus anticoagulant (LA) (Taha and Samavati, 2021).